Pratheesh K. Poyil
Riyadh, 11211, Saudi Arabia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
c-MET Overexpression Drives AKT Activation, and Combined Inhibition Synergistically Enhances Therapeutic Sensitivity in Non-Small-Cell Lung Cancer.
Journal: Cells
Published: May 16, 2026
All screens lead to polo-like kinase 1: A central node in cancer therapeutics and resistance.
Journal: Pharmacological research
Published: February 04, 2026
Polo-like Kinase 1 Predicts Lymph Node Metastasis in Middle Eastern Colorectal Cancer Patients; Its Inhibition Reverses 5-Fu Resistance in Colorectal Cancer Cells.
Journal: Cells
Published: September 03, 2024
PLK1 and FoxM1 expressions positively correlate in papillary thyroid carcinoma and their combined inhibition results in synergistic anti-tumor effects.
Journal: Molecular oncology
Published: September 18, 2023
PLK1 and PARP positively correlate in Middle Eastern breast cancer and their combined inhibition overcomes PARP inhibitor resistance in triple negative breast cancer.
Journal: Frontiers in oncology
Published: August 31, 2023
Overexpression of the pro-protein convertase furin predicts prognosis and promotes papillary thyroid carcinoma progression and metastasis through RAF/MEK signaling.
Journal: Molecular oncology
Published: August 13, 2022
Loss of ZNF677 Expression Is an Independent Predictor for Distant Metastasis in Middle Eastern Papillary Thyroid Carcinoma Patients.
Journal: International journal of molecular sciences
Published: May 05, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026